Molecular characterization of multidrug resistant Acinetobacter baumannii clinical isolates from Alexandria, Egypt

1 Introduction

Carbapenem resistant Acinetobacter baumannii (CRAB) is one of the major global threats for healthcare settings worldwide, as there are only few antibiotics effective to treat the infections caused by these isolates due to its high rates of antimicrobial resistance (Ejaz et al., 2021). This pathogen is responsible for multiple nosocomial infections such as bloodstream infections, urinary tract infections, wound infections, ventilator-associated pneumonia and other respiratory tract infections, meningitis and bacteremia (Kurihara et al., 2020). As a consequence, A. baumannii is heading the World Head Organization’s (WHO) list of critical pathogens for which new antibiotics are urgently needed (El-Kholy et al., 2021). Many other global institutions such as the European Centre for Disease Prevention and Control (ECDC), Infectious Diseases Society of America (IDSA) and the Center for Disease Control and Prevention of America (CDC) have also declared it an urgent threat (Mea et al., 2021).

Rates of mortality and disability caused by A. baumannii infections are increasing. Retrospective studies showed that the mortality rates associated with A. baumannii infections are ranging from 22.8% to 49.6% in the United States (US), and from 29% to 71.6% in Europe (Patel et al., 2019). According to autores, mortality associated with A. baumannii causing hospital-acquired and ventilator-associated pneumonia was higher in Western Asia (56.2%), Southern Europe (55.7%) and Northern Africa (53.3%). Countries of the Mediterranean area, such as Greece (68.2%), Turkey (61.4) or Egypt (53.3%) were the ones with the highest reported mortality rates (Mohd Sazlly Lim et al., 2019). Indeed, in Egypt 30–100% of A. baumannii isolates are considered as Multidrug-Resistant (MDR), and carbapenem resistance was reported in 26.6–100% of A. baumannii isolates (El-Kholy et al., 2021). Furthermore, many reports showed that the COVID-19 pandemic increased CRAB infection rates, for instance in the US, the rates in hospitals increased a 78% and overall by 35% in 2020 compared with 2019 (Centers for Disease Control and Prevention, 2022). In Egypt, MDR A. baumannii was the second most common cause of infection (27.4%) among mechanically ventilated patients during the second wave of COVID-19 (Elwakil et al., 2023). The economic impact is also remarkable in CRAB infections, for instance in the United States, the CDC reported that treatment costs were around $281 million in 2019 (Ejaz et al., 2021).

Different resistance mechanisms are commonly found in A. baumannii including antibiotic inactivation enzymes, alteration of target sites, overexpression of efflux pumps and loss of porins (Chakravarty, 2020). Carbapenemases are the main carbapenem resistance mechanism in A. baumannii, being carbapenem-hydrolyzing oxacilinases the most important ones. However, during the last years, class B metallo-β-lactamases such as New Delhi Metallo-Beta-lactamases (NDM) are on the rise (Xanthopoulou et al., 2020).

Nine major International Clones (IC1-9) of A. baumannii, have been described up to now, being IC2/CC92 with the acquired bla_OXA-23 gene the most disseminated lineage worldwide (Al-Hassan et al., 2019; Al-Hassan et al., 2021); and IC1 and IC2 in Europe (Muthuirulandi Sethuvel et al., 2019). In the Middle East and North Africa, A. baumannii clinical outbreaks, caused by MDR isolates endemically producing carbapenemases NDM-1, NDM-2 and OXA-23, are usually poly-clonal but with dominance of IC2 lineage (Hassan et al., 2021). Although IC2 is the most disseminated clone in Northern Africa, isolates belonging to IC5 and IC9 are also reported (Al-Hassan et al., 2021; Hamed et al., 2022). From 2013 to date, isolates belonging to Oxford ST208 (IC2), are commonly reported in Egyptian hospitals (Al-Hassan et al., 2019). However, in spite of the alarming situation, there is little information about A. baumannii in Egypt and more studies are needed (Hassan et al., 2021). Nevertheless, the limited resources for research in low- and middle-income countries such as Egypt, makes it difficult to obtain epidemiological data. It is of high concern to investigate the molecular epidemiology to control the dissemination of these clinically important isolates.

The aim of the present study was to characterize the genetic features, to study the molecular epidemiology and to identify the antimicrobial susceptibility profiles of thirty-six carbapenem resistant A. baumannii clinical isolates obtained from hospitals from Alexandria, Egypt.

2 Materials and methods

2.1 Bacterial isolates, species identification and antimicrobial susceptibility testing

Thirty-six A. baumannii isolates were collected from August 2020 to February 2021 in hospitals from Alexandria, Egypt and processed and identified in the Medical Research Institute of Alexandria. The bacterial isolates were from 21 male and 15 female patients. Clinical samples were obtained from the following sources: bronchoalveolar lavage (14), swab (8), blood (5), aspirate (3), sputum (3), endotracheal tube (1), urine (1) and tissue (1).

Species identification was assessed by VITEK 2^® automated system (Biomérieux, Marcy-l’Étoile, France) and gyrB multiplex PCR (Higgins et al., 2010b). Minimum Inhibitory Concentrations (MICs) to ticarcillin, ticarcillin/clavulanic acid, piperacillin, piperacillin/tazobactam, ceftazidime, cefepime, amikacin, gentamicin, tobramycin, minocycline, ciprofloxacin, trimethoprim/sulfamethoxazole, imipenem, meropenem and colistin were determined by the use of VITEK 2^® automated system. Antimicrobial activity of cefiderocol was determined by disk diffusion method using 30 µg cefiderocol discs (ThermoFisher Scientific, Waltham, United States) following the EUCAST guidelines and clinical breakpoints (Versions 10.0 and 12.0, January 2022). Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 were used as control strains.

2.2 Detection of carbapenemase genes

Carbapenemase-encoding genes were analyzed by multiplex PCR including primers for: bla_{OXA-23-like, −40-like, −51-like, −58-like, −143-like}, _{and −235-like} (Woodford et al., 2006; Higgins et al., 2010a; Higgins et al., 2013). Two additional multiplex PCR were performed to investigate the presence of bla_VIM, bla_KPC, bla_NDM, bla_OXA-48, bla_IMI, bla_GES, bla_GIM, bla_IMP and ISAba-1/bla_OXA-51-like (Cerezales et al., 2021).

2.3 Whole Genome Sequencing, genome annotation, analysis and visualization and virulence factors analysis

Total DNA was purified with the DNeasy Blood and Tissue Kit (Qiagen, Hilden, Germany) and sequenced on a MiSeq device using reagents kit v3 for 2×300 paired-end libraries (Illumina) as previously described (Hernández et al., 2017). Raw reads from the sequencing platform were directly analyzed using the in-house bioinformatics pipeline TORMES^® (Quijada et al., 2019). A. baumannii ATCC 17978 was used as reference strain. The options used in this study included quality control and filtering of the reads by using Trimmomatic (Bolger et al., 2014), Prinseq (Schmieder and Edwards, 2011) and Kraken (Wood and Salzberg, 2014). Genome assembly was performed with SPAdes (Bankevich et al., 2012) and Quast (Gurevich et al., 2013) and genome annotation with Prokka software tool (Seemann, 2014). The whole-genome shotgun sequences of the isolates generated for this study were deposited and can be found in GenBank under the BioProject accession number PRJNA856145 and the accession numbers of each isolate are detailed in Supplementary Table 1. Search of antibiotic resistance genes was done using BLAST (Camacho et al., 2009) and ABRicate (https://github.com/tseemann/abricate (accessed on October 2021)) against ResFinder database (Zankari et al., 2012). Genome was edited and visualized by the use of SnapGene Viewer 6.0.5. Virulence factors were screened using Virulence Factors Database (VFDB) search tool (Liu et al., 2019) and Ridom SeqSphere+ software version 8.5.1 (Ridom GmbH,Münster, Germany).

2.4 Surface-associated motility

Motility assay was performed on Motility Test Medium (Condalab, Madrid, Spain) inoculated on the surface and incubated overnight at 37°C following manufacturer instructions.

2.5 Biofilm formation assays

Biofilm production was evaluated using the crystal violet staining assay described by O’Toole and Kolter as described before (O'Toole and Kolter, 1998) with slight modifications. Briefly, A. baumannii overnight cultures were adjusted to a 0.5 McFarland turbidity in 0.85% saline solution. Biofilms were developed in 24-well flat-bottom plates (Sarstedt^®, Nümbrecht, Germany). First, bacterial suspensions were incubated at 37°C for 24 h. Then, biofilms were washed, air-dried and stained with 1 mL/well of 0.7% crystal violet solution (Sigma-Aldrich). Finally, stained biofilms were solubilized with 1mL/well of 33% acetic acid solution (Sigma-Aldrich).Biofilm production was determined at 600 nm using the Tecan Infinite M200 Pro Microplate Reader (Tecan Group Ltd., Männedorf, Suiza). Results were corrected for background staining by subtracting the value for crystal violet bound to uninoculated Müller Hinton Broth control wells. Isolates E. coli J53 and P. aeruginosa PAO1 were used as negative and positive controls, respectively. The experiments were performed in triplicate and repeated in three different days with similar results.

2.6 Molecular typing

Multi-Locus Sequence Typing (MLST) was performed using an open-source tool (MLST, T. Seemann, https://github.com/tseemann/mlst (accessed on October 2021) following Pasteur typing scheme. The bla_OXA-51-like variant combined with the Sequence Type (ST) were used to assign the isolate to an International Clone (IC). Core genome MLST (cgMLST) based on a core genome of 2390 alleles was also carried out to study clonal relatedness by the use of Ridom SeqSphere+ software version 8.5.1 (Ridom GmbH) and a minimum spanning tree was generated.

2.7 Plasmid analysis and carbapenemase genes localization

Plasmid extractions were carried out by the use of GeneJET Plasmid Miniprep Kit following manufacturer indications (ThermoFisher Scientific, Waltham, Massachusetts, USA) and S1-Pulsed-Field Gel Electrophoresis (PFGE). Bacterial DNA embedded in agarose plugs was digested using 14 units of S1-nuclease (Takara Bio, Kusatsu, Japan) per plug followed by PFGE. Samples were run on a CHEF-DR III system (Bio-Rad, Munich, Germany) for 20 h at 6 V/cm and 14°C. CHEF DNA Size Standard Lambda Ladder (Bio-Rad) was used as molecular weight marker. Southern blot hybridizations were performed to locate bla_NDM-1, bla_PER-7 and bla_GES-like genes with specific digoxigenin-labeled DNA probes (Roche, Mannheim, Germany). Signal detection was performed using DIG Nucleic Acid Detection Kit (Roche). Determination of the presence and classification of replicase genes was conducted using A. baumannii PCR-Based Replicon Typing as previously described (Bertini et al., 2010).

3 Results

3.1 Bacterial isolates, species identification and antimicrobial susceptibility testing

The thirty-six bacterial isolates were identified by VITEK 2^® and gyrB multiplex PCR as A. baumannii (Supplementary Figure 1). Fifty-eight percent of the isolates were from male patients vs. forty-two percent from female patients. Data regarding to collection date, sex and type of sample are shown in Supplementary Table 1.

All isolates were resistant to ticarcillin, ticarcillin/clavulanic acid, piperacillin, piperacillin/tazobactam and ciprofloxacin. High resistance rates were also found for both imipenem and meropenem (94.4%). Resistance to gentamicin was observed in 80.5% of the isolates, whereas 75% of the isolates were resistant to tobramycin and trimethoprim/sulfamethoxazole. It is worth mentioning that cefiderocol resistance was found in 22.2% of the isolates and 16.7% were resistant to minocycline. No colistin-resistant isolates were found (Supplementary Table 2).

3.2 Antibiotic resistance genes identification by Whole Genome Sequencing

Sequencing results showed 8 different bla_OXA-51-like variants including bla_OXA-51, bla_OXA-64, bla_OXA-65, bla_OXA-66, bla_OXA-68, bla_OXA-91, bla_OXA-94 and bla_OXA-336 (Table 1). Genes bla_OXA-66 and bla_OXA-65 were found in 16 and 10 isolates, respectively. Thirty-four isolates contained the bla_OXA-23 gene, but the isolate Ale28 showed a 4bp deletion at position 203 of the gene leading to a premature stop codon at position 203 causing a lack of the protein expression. The presence of the bla_NDM-1 carbapenemase gene was detected in ten isolates. Other β-lactamase genes such as bla_GES-35 (6), bla_GES-11 (3), bla_PER-7 (4), bla_ADC-73 (15), bla_ADC-117 (9), bla_ADC-211 (1), bla_ADC-143 (2), bla_ADC-263 (2), bla_ADC-80 (3), bla_ADC-25 (1), bla_ADC-259 (1), bla_ADC-57 (1), bla_ADC-52 (1), bla_ADC-199 (1) and bla_TEM-1 (15) were detected.

TABLE 1

Table 1 Clonal lineages (Pasteur Sequence Type (ST) and International Clone (IC)) and β-lactamase genes identified through sequencing experiments.

Other antibiotic resistance genes were also detected including genes conferring resistance to trimethoprim (dfrA7), tetracyclines (tet(B), tet(39)), sulfonamides (sul1, sul2), aminoglycosides (armA, strA, strB, aph(3’)-Ia, aph(3’)-VI, aph(3’)-VIa, aac(6’)-Ib, ant(3’’)-II, ant(3’’)-IIa, aadA1-pm), macrolides (mph(E), msr(E)), rifamycin (arr-2) and chloramphenicol (cmlA5, catB8, catA1) (Table 2). Genes conferring resistance to aminoglycosides were especially abundant and present in the majority of the isolates. Genes coding for efflux pumps and their regulators were also detected including abeM (MATE family); abeS (SMR family); amvA, abaF and abaQ (MFS family); adeA, adeB, adeC, adeF, adeG, adeH, adeI, adeJ,adeK, adeL, adeN, adeR and adeS (RND family).

TABLE 2

Table 2 Additional antibiotic resistance genes detected by Whole Genome Sequencing.

3.3 Genetic surroundings of β-lactamase genes

The genetic contexts of the β-lactamase coding genes are shown in Figure 1. Regarding to bla_OXA-23, it was located within Tn2006 in the singleton and isolates belonging to IC2, IC4 and IC7; and within Tn2008 transposons in isolates belonging to IC9 and IC5 (Figure 1B). In all the isolates harboring bla_NDM-1, the gene was within the truncated isoform of transposon Tn125 (ΔTn125) (Figure 1C). We found the bla_PER-7 gene located within a complex structure of ISCR1 element and class 1 integron with part of IS26 upstream the integron in all the isolates carrying the gene (Figure 1D). The bla_GES-like genes were located within a class 1 integron accompanied by other resistance genes such as aac(6´)-Ib, dfrA7 and sul1 (Figure 1E). We did not find insertion sequences upstream any of the bla_OXA-51-like variants (Figure 1A).

FIGURE 1

Figure 1 Genetic contexts of bla_OXA-51-like variants (A), bla_OXA-23 (B), bla_NDM-1 (C), bla_PER-7 (D) and bla_GES-like variants (E).

3.4 Molecular typing and clonal relatedness

Isolates were assigned to nine Pasteur STs and clustered in six different International Clones, including IC2, IC4, IC5, IC7, IC8 and IC9 (Figure 2). One isolate assigned to ST164 was not related to any described IC.

FIGURE 2

Figure 2 Minimum spanning tree of 36 A. baumannii isolates based on 2390 target alleles (core genome) generated using Ridom SeqSphere+ software. The study IDs of the isolates are shown within the nodes. Isolates are colored based on the assigned Pasteur STs and clustered by the International Clones they belong to.

3.5 Virulence factors analysis

Virulome analysis of each International Clone and the singleton showed the presence of multiple virulence factors responsible for adherence (Acinetobacter trimeric autotransporter ATA and type IV pili), biofilm production (AdeFGH efflux pump, biofilm associated protein BAP, Csu fimbriae, Poly-N-acetyl-D-glucosamine, biofilm-controlling response regulator and quorum sensing), type II and type VI secretion systems, exotoxins (phospholipases C and D), exoenzymes (coagulation targeting metallo-endopeptidase CpaA), immune modulation (capsule, lipopolysaccharide, outer membrane protein OmpA and penicillin-binding Protein G) and iron uptake (acinetobactin and HemO cluster). The gene coding for the coagulation targeting metallo-endopeptidase (cpaA) was just observed in IC8 and IC9, and ata gene coding for Acinetobacter trimeric autotransporter was present in isolates from IC2, IC4, IC5 and in the singleton. The bap gene was detected in the isolates belonging to IC2, IC4, IC5 and IC8.

3.6 Motility phenotypes

Different motility phenotypes were observed in all isolates, except to Ale36 and Ale1. A cloud-like morphology with well-defined edges was observed in the majority of isolates, although some isolates radiated uniformly from the inoculation point presenting a positive control-like morphology.

3.7 Biofilm formation assays

Varying degrees of biofilm production were observed among the isolates (Figure 3). It was observed that stronger biofilm-producers belonged to IC2, IC4 and IC7 and were isolated from BAL/miniBAL and swabs (Ale30, Ale21, Ale25, Ale38, Ale27 and Ale1). Especially remarkable was the strong biofilm production capacity of the singleton Ale30, which showed even a higher biofilm production than the positive control.

FIGURE 3

Figure 3 Biofilm production means ± standard deviations of the A. baumannii isolates. E. coli J53 and P. aeruginosa PAO1 were used as negative and positive controls, respectively.

3.8 Plasmid analysis and genetic localization of bla_NDM-1, bla_PER-7 and bla_GES-like genes

Plasmids ranging in size from 1.7 to 70 kb were observed (Figure 4A). Hybridization experiments located the bla_NDM-1 gene in the chromosome (Figure 4B). Chromosomic localization of bla_PER-7 gene was also confirmed (Figure 4C). The bla_GES-like genes were located in the chromosome in all the isolates, and simultaneously located in a plasmid of approximately 70kb in five isolates (Figure 4D). Replicon typing experiments showed the presence of genes coding for previously described replicases Aci1/Aci2, Aci4, Aci6, Aci8/Aci9, p2S1 and pAB49 pertaining to homology groups 2, 4, 6, 8, 12 and 16, respectively, in all the isolates except to Ale4. Twenty-one isolates showed a combination of two replicases: Aci1/Aci2 + Aci6 (6); Aci1/Aci2 + p2S1 (1); p2S1+Aci6 (10); Aci8/9 + Aci6 (1); Aci4+Aci8/Aci9 (3).

FIGURE 4

Figure 4 Plasmid profiles and hybridization experiments of the A. baumannii isolates. (A) plasmid profiles of the six identified International Clones and the singleton (Sin.); (B) hybridization signal in the chromosome with the bla_NDM-1 probe; (C) hybridization signal in the chromosome with the bla_PER-7 probe; (D) hybridization signal in the chromosome with the bla_GES-like probe in lane 1 and hybridization signal in a 70kb plasmid in lane 2.

4 Discussion

It is said that the lack of regulation and the abuse in the use of antibiotics in Egypt are the main cause of the acceleration in the emergence of resistant isolates, and also responsible for exporting resistance to other countries (Elwakil et al., 2023). In the present study, 94.4% of carbapenem, 100% of fluoroquinolone and 86.11% of aminoglycoside resistance was observed, which is consistent with previous studies reporting a carbapenem resistance of 98% with elevated levels of resistance to quinolones and aminoglycosides in Mansoura, Egypt (Said et al., 2018). In fact, our isolates showed higher aminoglycoside resistance ratios than the resistance reported in recent studies from Egypt (up to 82% and 67%) (ELsheredy et al., 2021; Kishk et al., 2021). To our knowledge, up to date, no cefiderocol resistant isolates have been reported in Egypt apart from the eight resistant isolates analyzed in our study. Fortunately, isolates remained susceptible to colistin, although colistin resistance was reported in up to 53% of A. baumannii Egyptian isolates according to studies published in 2020 (Fam et al., 2020; Makharita et al., 2020).

WGS analysis showed bla_OXA-66 and bla_OXA-65 as the most frequent bla_OXA-51-like variants among the isolates, which is consistent with the high prevalence of bla_OXA-66 in North Africa and the Middle East (Muthuirulandi Sethuvel et al., 2019) but not with the reported prevalence of bla_OXA-65 in Egypt (Elwakil et al., 2023). A higher prevalence of bla_OXA-51 has been reported in Egypt during the last years, while other variants described in this study have been reported less frequently in Egypt (Elwakil et al., 2023). The genetic contexts of the bla_OXA-51-like variants found in our isolates, were similar to those found in previously described isolates (Vijayakumar et al., 2022). Although ISAba is a commonly found element upstream these genes, not all the variants harbor it necessarily. The most common acquired carbapenemase gene found in these isolates was bla_OXA-23, which is usually found in 90–100% of carbapenem-resistant A. baumannii isolates in Egypt (Abouelfetouh et al., 2019; Hassan et al., 2021). This gene was located within Tn2006 or Tn2008 transposons as previously described, which is crucial for the overexpression and mobilization of bla_OXA-23 (Hamidian and Nigro, 2019). Regarding to bla_GES-like genes, these type of Extended-Spectrum β-Lactamase genes have been increasingly reported during the last years, and some of its variants can possess carbapenemase activity (Bonnin Rémy et al., 2013). These type of β-Lactamase genes are frequently reported in the Mediterranean Area and the Middle East countries such as Turkey, Tunisia, or Kuwait (Bonnin Rémy et al., 2013; Cicek et al., 2014; Chihi et al., 2016). However, in our study, these genes were identified in 25% of the isolates, half of the frequency reported in other studies in Egypt (50%) (Ramadan et al., 2018). As previously described in isolates from Pakistan, bla_GES-like genes were part of a class 1 integron co-harboring dfrA7, sul1 and aac(6’)-Ib resistance genes (Karah et al., 2020). Furthermore, bla_OXA-23 and bla_GES-11 genes have been described encoded in a large conjugative plasmid named pK50a (79.6kb) which is a member of the Aci6 group (Wibberg et al., 2018). This is approximately of the same size as the plasmid in which we identified the bla_GES-11 gene, and it is worth mentioning that all the isolates harboring bla_GES-like genes were positive for replicase Aci6 too. The bla_NDM-1 gene was detected in 27.8% of isolates, in concordance with the literature where NDM-type carbapenemases are commonly reported in Egyptian isolates with a prevalence of 0–39.3% (El-Kholy et al., 2021). This gene was found within the truncated isoform of Tn125 (ΔTn125) in our isolates with the characteristic ISAba125 upstream of the bla_NDM-1 gene which appears to enhance its expression (Wang et al., 2012). In all the isolates, bla_NDM-1 gene was chromosome-borne, which is the most frequent localization (Fernández-Cuenca et al., 2020). The bla_PER-7 gene was located within a complex structure connecting ISCR1 element and class 1 integron, which is a previously described structure closely related to multidrug resistant bacteria (Cheng et al., 2016). However, another ISCR1 element, IS5 and part of IS10A were identified downstream of the 3’-CS which differs from the described structure. NDM-type carbapenemases and PER-type β-lactamases seem to be involved in cefiderocol resistance, the recently developed last resort antibiotic (Naeimi Mazraeh et al., 2021; Poirel et al., 2021).

Analysis of the sequenced genomes showed that seventeen isolates belonged to IC2 with the characteristic bla_OXA-66 gene, which is the dominant clone circulating worldwide and in Egypt (Hassan et al., 2021). Among this lineage, ST570 was the most abundant clade, an ST which has four entries in the PubMLST database, submitted from Vietnam (1) and Egypt (3) indicating that this lineage is circulating in Egyptian health settings at least, since 2017. Regarding to ST2, among 1319 isolates submitted to the database, two entries from Egypt between 2013 and 2015, and eight entries from Jordan between 2019 and 2020 were found. A recent study showed six out of seven Syrian strains pertaining to ST2 (Higgins et al., 2021), demonstrating that ST2 is commonly circulating between countries of the Mediterranean area. The less abundant clade was ST600, which has five entries in the PubMLST database isolated from Jordan (4) and Libya (1), between 2014 and 2020, suggesting a possible transmission between these two nearby countries during these years. Ten isolates belonged to IC5 (ST158) harbouring the characteristic bla_OXA-65 gene. Four isolates were identified in the PubMLST database isolated from Iraq, Turkey, Russia and Egypt; consistent with a study published in 2020 in Egypt, where the majority of the isolates belonged to ST158, indicating that this clone is circulating in the Mediterranean and Middle East area (Elwakil et al., 2023). Three isolates belonged to IC4 (ST15), a ST which is predominantly found in Latin American countries, although it has also been described in countries of the Mediterranean are such as Turkey (Di Popolo et al., 2011). Three isolates were related to IC9 (ST85), which have been recently reported in Libya (Higgins et al., 2021). A search in PubMLST also showed four entries in Jordan during 2020 and one in Egypt in 2017 demonstrating the presence of this clade in Egypt and the Middle East area. Just one isolate belonging to IC7(ST113) was identified, a sequence type frequently reported in South America (Kurihara et al., 2020) although, it has also been described in Cairo in 5 isolates from 2018 to 2020 according to PubMLST. A single isolate pertaining to IC8(ST613) was detected, this is a linage with little presence in the Middle East and North Africa, with just one isolate reported in Alexandria in 2013 according to PubMLST. A singleton assigned to ST164 was identified among our isolates, this ST have been identified in Germany in 2021 (Wareth et al., 2021) and in Turkey in 2016. There are no public records of isolates belonging to this linage in Egypt up to date.

In conclusion, this study showed a high clonal diversity among CRAB isolates collected from hospitals in Alexandria, and highlights the emergence of not frequently reported lineages in Egypt. The high incidence of bla_OXA-23 carbapenemase as well as bla_NDM-1 is of concern as they are key in carbapenem resistance and to many other antibiotics. This work also puts the spotlight in the emergence of cefiderocol resistant isolates in Egyptian hospitals. It becomes necessary to harden infection control measures and to increase epidemiologic studies in Egypt to limit the development of new clones with highly resistant genes.

Data availability statement

The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material.

Author contributions

SS-U, LG and IA contributed to the design of the experiments and were responsible for the project funding. SS-U, AM-B, AO-S, MH and DA performed the experiments. SS-U, AO-S and LG analyzed and interpreted the data. SS-U and LG wrote the manuscript. SMS and ME-K were responsible for the collection, identification and determination of the resistance profile of the isolates. All authors contributed to the article and approved the submitted version.

Funding

This study was financially supported by the Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033) [Grant PID2020-116495RB-I00]; the Department of Education, Basque Government (Research Groups of the Basque University System 2021 [Group IT1578-22, GIC21/18]; and the Arab Academy for Science, Technology and Maritime Transport [Grant Number 2072].

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcimb.2023.1208046/full#supplementary-material

References

Abouelfetouh, A., Torky, A. S., Aboulmagd, E. (2019). Phenotypic and genotypic characterization of carbapenem-resistant Acinetobacter baumannii isolates from Egypt. Antimicrobial resistance infection control 8, 185–186. doi: 10.1186/s13756-019-0611-6

PubMed Abstract | CrossRef Full Text | Google Scholar

Al-Hassan, L., Elbadawi, H., Osman, E., Ali, S., Elhag, K., Cantillon, D., et al. (2021). Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii from Khartoum State, Sudan. Front. Microbiol. 12. doi: 10.3389/fmicb.2021.628736

PubMed Abstract | CrossRef Full Text | Google Scholar

Al-Hassan, L., Zafer, M. M., El-Mahallawy, H. (2019). Multiple sequence types responsible for healthcare-associated Acinetobacter baumannii dissemination in a single centre in Egypt. BMC Infect. Dis. 19 (1), 829. doi: 10.1186/s12879-019-4433-1

PubMed Abstract | CrossRef Full Text | Google Scholar

Bankevich, A., Nurk, S., Antipov, D., Gurevich, A. A., Dvorkin, M., Kulikov, A. S., et al. (2012). SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J. Comput. Biol. 19 (5), 455–477. doi: 10.1089/cmb.2012.0021

PubMed Abstract | CrossRef Full Text | Google Scholar

Bertini, A., Poirel, L., Mugnier, P. D., Villa, L., Nordmann, P., Carattoli, A. (2010). Characterization and PCR-based replicon typing of resistance plasmids in Acinetobacter baumannii. Antimicrobial Agents Chemotherapy 54 (10), 4168–4177. doi: 10.1128/AAC.00542-10

PubMed Abstract | CrossRef Full Text | Google Scholar

Bolger, A. M., Lohse, M., Usadel, B. (2014). Trimmomatic: a flexible trimmer for illumina sequence data. Bioinformatics 30 (15), 2114–2120. doi: 10.1093/bioinformatics/btu170

PubMed Abstract | CrossRef Full Text | Google Scholar

Bonnin Rémy, A., Rotimi Vincent, O., Al, H. M., Elise, G., Al, S. N., Patrice, N., et al. (2013). Wide dissemination of GES-type carbapenemases in Acinetobacter baumannii isolates in Kuwait. Antimicrobial Agents Chemotherapy 57 (1), 183–188. doi: 10.1128/aac.01384-12

PubMed Abstract | CrossRef Full Text | Google Scholar

Camacho, C., Coulouris, G., Avagyan, V., Ma, N., Papadopoulos, J., Bealer, K., et al. (2009). BLAST+: architecture and applications. BMC Bioinf. 10 (1), 421. doi: 10.1186/1471-2105-10-421

CrossRef Full Text | Google Scholar

Centers for Disease Control and Prevention (2022) COVID-19: U.S. impact on antimicrobial resistance, special report 2022 (Hyattsville, MD). Available at: https://stacks.cdc.gov/view/cdc/117915 (Accessed 16th of March,2023).

Google Scholar

Cerezales, M., Biniossek, L., Gerson, S., Xanthopoulou, K., Wille, J., Wohlfarth, E., et al. (2021). Novel multiplex PCRs for detection of the most prevalent carbapenemase genes in gram-negative bacteria within Germany. J. Med. Microbiol. 70 (3), 1310. doi: 10.1099/jmm.0.001310

CrossRef Full Text | Google Scholar

Chakravarty, B. (2020). Genetic mechanisms of antibiotic resistance and virulence in Acinetobacter baumannii: background, challenges and future prospects. Mol. Biol. Rep. 47 (5), 4037–4046. doi: 10.1007/s11033-020-05389-4

PubMed Abstract | CrossRef Full Text | Google Scholar

Cheng, C., Sun, J., Zheng, F., Lu, W., Yang, Q., Rui, Y. (2016). New structures simultaneously harboring class 1 integron and ISCR1-linked resistance genes in multidrug-resistant gram-negative bacteria. BMC Microbiol. 16 (1), 71. doi: 10.1186/s12866-016-0683-x

PubMed Abstract | CrossRef Full Text | Google Scholar

Chihi, H., Bonnin, R. A., Bourouis, A., Mahrouki, S., Besbes, S., Moussa, M. B., et al. (2016). GES-11-producing Acinetobacter baumannii clinical isolates from Tunisian hospitals: long-term dissemination of GES-type carbapenemases in north Africa. J. Global Antimicrobial Resistance 5, 47–50. doi: 10.1016/j.jgar.2016.03.005

CrossRef Full Text | Google Scholar

Cicek, A. C., Saral, A., Iraz, M., Ceylan, A., Duzgun, A. O., Peleg, A. Y., et al. (2014). OXA- and GES-type β-lactamases predominate in extensively drug-resistant Acinetobacter baumannii isolates from a Turkish University Hospital. Clin. Microbiol. infection 20 (5), 410–415. doi: 10.1111/1469-0691.12338

CrossRef Full Text | Google Scholar

Di Popolo, A., Giannouli, M., Triassi, M., Brisse, S., Zarrilli, R. (2011). Molecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing scheme. Clin. Microbiol. Infection 17 (2), 197–201. doi: 10.1111/j.1469-0691.2010.03254.x

CrossRef Full Text | Google Scholar

Ejaz, H., Ahmad, M., Younas, S., Junaid, K., Abosalif, K. O. A., Abdalla, A. E., et al. (2021). Molecular epidemiology of extensively-drug resistant Acinetobacter baumannii sequence type 2 Co-harboring bla_NDM and bla_OXA from clinical origin. Infection Drug Resistance 14, 1931–1939. doi: 10.2147/IDR.S310478

PubMed Abstract | CrossRef Full Text | Google Scholar

El-Kholy, A., El-Mahallawy, H. A., Elsharnouby, N., Abdel Aziz, M., Helmy, A. M., Kotb, R. (2021). Landscape of multidrug-resistant gram-negative infections in Egypt: survey and literature review. Infection Drug Resistance 14, 1905–1920. doi: 10.2147/IDR.S298920

PubMed Abstract | CrossRef Full Text | Google Scholar

ELsheredy, A., Yousif, Z., Elghazzawi, E., Elmenshawy, A., Ghazal, A. (2021). Prevalence of genes encoding aminoglycoside-modifying enzymes and armA among Acinetobacter baumannii clinical isolates in Alexandria, Egypt. Infect. Disord. Drug Targets 21 (8), e300821191828. doi: 10.2174/1871526521666210225113041

PubMed Abstract | CrossRef Full Text | Google Scholar

Elwakil, W. H., Rizk, S. S., El-Halawany, A., Rateb, M. E., Attia, A. S. (2023). Multidrug-resistant Acinetobacter baumannii infections in the United Kingdom versus Egypt: trends and potential natural products solutions. Antibiotics 12 (1), 77. doi: 10.3390/antibiotics12010077

PubMed Abstract | CrossRef Full Text | Google Scholar

Fam, N. S., Gamal, D., Mohamed, S. H., Wasfy, R. M., Soliman, M. S., El-Kholy, A. A., et al. (2020). Molecular characterization of Carbapenem/Colistin-resistant Acinetobacter baumannii clinical isolates from Egypt by whole-genome sequencing. Infection Drug resistance 13, 4487–4493. doi: 10.2147/IDR.S288865

PubMed Abstract | CrossRef Full Text | Google Scholar

Fernández-Cuenca, F., Pérez-Palacios, P., Galán-Sánchez, F., López-Cerero, L., López-Hernández, I., López Rojas, R., et al. (2020). First identification of blaNDM-1 carbapenemase in blaOXA-94-producing Acinetobacter baumannii ST85 in Spain. Enfermedades Infecciosas y Microbiología Clínica 38 (1), 11–15. doi: 10.1016/j.eimc.2019.03.008

PubMed Abstract | CrossRef Full Text | Google Scholar

Gurevich, A., Saveliev, V., Vyahhi, N., Tesler, G. (2013). QUAST: quality assessment tool for genome assemblies. Bioinf. (Oxford England) 29 (8), 1072–1075. doi: 10.1093/bioinformatics/btt086

CrossRef Full Text | Google Scholar

Hamed, S. M., Hussein, A. F. A., Al-Agamy, M., Radwan, H. H., Zafer, M. M. (2022). Genetic configuration of genomic resistance islands in Acinetobacter baumannii clinical isolates from Egypt. Front. Microbiol. 13. doi: 10.3389/fmicb.2022.878912

CrossRef Full Text | Google Scholar

Hamidian, M., Nigro, S. J. (2019). Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii. Microbial Genomics 5 (10), e000306. doi: 10.1099/mgen.0.000306

PubMed Abstract | CrossRef Full Text | Google Scholar

Hassan, R. M., Salem, S. T., Hassan, S. I. M., Hegab, A. S., Elkholy, Y. S. (2021). Molecular characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates from Egyptian patients. PloS One 16 (6), e0251508. doi: 10.1371/journal.pone.0251508

PubMed Abstract | CrossRef Full Text | Google Scholar

Hernández, M., Iglesias, M. R., Rodríguez-Lázaro, D., Gallardo, A., Quijada, N., Miguela-Villoldo, P., et al. (2017). Co-Occurrence of colistin-resistance genes mcr-1 and mcr-3 among multidrug-resistant Escherichia coli isolated from cattle, Spain, September 2015. Euro Surveillance: Bull. Europeen Sur Les Maladies Transmissibles = Eur. Communicable Dis. Bull. 22 (31), 77. doi: 10.2807/1560-7917.ES.2017.22.31.30586

CrossRef Full Text | Google Scholar

Higgins, P. G., Hagen, R. M., Kreikemeyer, B., Warnke, P., Podbielski, A., Frickmann, H., et al. (2021). Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates from Northern Africa and the Middle East. Antibiotics (Basel Switzerland) 10 (3), 291. doi: 10.3390/antibiotics10030291

PubMed Abstract | CrossRef Full Text | Google Scholar

Higgins, P. G., Lehmann, M., Seifert, H. (2010a). Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrobial Agents 35 (3), 305. doi: 10.1016/j.ijantimicag.2009.10.014

CrossRef Full Text | Google Scholar

Higgins, P. G., Lehmann, M., Wisplinghoff, H., Seifert, H. (2010b). gyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3. J. Clin. Microbiol. 48 (12), 4592–4594. doi: 10.1128/JCM.01765-10

PubMed Abstract | CrossRef Full Text | Google Scholar

Higgins, P. G., Pérez-Llarena, F. J., Zander, E., Fernández, A., Bou, G., Seifert, H. (2013). OXA-235, a novel class d β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrobial Agents Chemotherapy 57 (5), 2121–2126. doi: 10.1128/AAC.02413-12

PubMed Abstract | CrossRef Full Text | Google Scholar

Karah, N., Khalid, F., Wai, S. N., Uhlin, B. E., Ahmad, I. (2020). Molecular epidemiology and antimicrobial resistance features of Acinetobacter baumannii clinical isolates from Pakistan. Ann. Clin. Microbiol. Antimicrobials 19 (1), 2. doi: 10.1186/s12941-019-0344-7

CrossRef Full Text | Google Scholar

Kishk, R., Soliman, N., Nemr, N., Eldesouki, R., Mahrous, N., Gobouri, A., et al. (2021). Prevalence of aminoglycoside resistance and aminoglycoside modifying enzymes in Acinetobacter baumannii among intensive care unit patients, Ismailia, Egypt. Infection Drug resistance 14, 143–150. doi: 10.2147/IDR.S290584

PubMed Abstract | CrossRef Full Text | Google Scholar

Kurihara, M. N. L., de Sales, R. O., da Silva, K. E., Maciel, W. G., Simionatto, S. (2020). Multidrug-resistant Acinetobacter baumannii outbreaks: a global problem in healthcare settings. Rev. da Sociedade Bras. Medicina Trop. 53, e20200248. doi: 10.1590/0037-8682-0248-2020

CrossRef Full Text | Google Scholar

Liu, B., Zheng, D., Jin, Q., Chen, L., Yang, J. (2019). VFDB 2019: a comparative pathogenomic platform with an interactive web interface. Nucleic Acids Res. 47 (D1), D687–D692. doi: 10.1093/nar/gky1080

PubMed Abstract | CrossRef Full Text | Google Scholar

Makharita, R. R., El-Kholy, I., Hetta, H. F., Abdelaziz, M. H., Hagagy, F. I., Ahmed, A. A., et al. (2020). Antibiogram and genetic characterization of carbapenem-resistant gram-negative pathogens incriminated in healthcare-associated infections. Infection Drug resistance 13, 3991–4002. doi: 10.2147/IDR.S276975

PubMed Abstract | CrossRef Full Text | Google Scholar

Mea, H. J., Yong, P. V. C., Wong, E. H. (2021). An overview of Acinetobacter baumannii pathogenesis: motility, adherence and biofilm formation. Microbiological Res. 247, 126722. doi: 10.1016/j.micres.2021.126722

CrossRef Full Text | Google Scholar

Mohd Sazlly Lim, S., Zainal Abidin, A., Liew, S. M., Roberts, J. A., Sime, F. B. (2019). The global prevalence of multidrug-resistance among Acinetobacter baumannii causing hospital-acquired and ventilator-associated pneumonia and its associated mortality: a systematic review and meta-analysis. J. Infection 79 (6), 593–600. doi: 10.1016/j.jinf.2019.09.012

CrossRef Full Text | Google Scholar

Muthuirulandi Sethuvel, D. P., Devanga Ragupathi, N. K., Bakthavatchalam, Y. D., Vijayakumar, S., Varghese, R., Shankar, C., et al. (2019). Current strategy for local- to global-level molecular epidemiological characterisation of global antimicrobial resistance surveillance system pathogens. Indian J. Med. Microbiol. 37 (2), 147–162. doi: 10.4103/ijmm.IJMM_19_396

PubMed Abstract | CrossRef Full Text | Google Scholar

Naeimi Mazraeh, F., Hasani, A., Sadeghi, J., Samadi Kafil, H., Soroush Barhaghi, M. H., Yeganeh Sefidan, F., et al. (2021). High frequency of blaPER-1 gene in clinical strains of Acinetobacter baumannii and its association with quorum sensing and virulence factors. Gene Rep. 24, 101232. doi: 10.1016/j.genrep.2021.101232

CrossRef Full Text | Google Scholar

O'Toole, G. A., Kolter, R. (1998). Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol. Microbiol. 28 (3), 449–461. doi: 10.1046/j.1365-2958.1998.00797.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Patel, R. V., Shah, J. S., Revathi, G., Siika, W., Shah, R. (2019). Acinetobacter infections: a retrospective study to determine inhospital mortality rate and clinical factors associated with mortality. Infection Prev. Pract. 1 (2), 100010. doi: 10.1016/j.infpip.2019.100010

CrossRef Full Text | Google Scholar

Poirel, L., Sadek, M., Nordmann, P. (2021). Contribution of PER-type and NDM-type β-lactamases to cefiderocol resistance in Acinetobacter baumannii. Antimicrobial Agents Chemotherapy 65 (10), e0087721. doi: 10.1128/AAC.00877-21

PubMed Abstract | CrossRef Full Text | Google Scholar

Quijada, N. M., Rodríguez-Lázaro, D., Eiros, J. M., Hernández, M. (2019). TORMES: an automated pipeline for whole bacterial genome analysis. Bioinformatics 35 (21), 4207–4212. doi: 10.1093/bioinformatics/btz220

PubMed Abstract | CrossRef Full Text | Google Scholar

Ramadan, R. A., Gebriel, M. G., Kadry, H. M., Mosallem, A. (2018). Carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: characterization of carbapenemase genes and e-test evaluation of colistin-based combinations. Infection Drug resistance 11, 1261–1269. doi: 10.2147/IDR.S170233

PubMed Abstract | CrossRef Full Text | Google Scholar

Said, H. S., Benmahmod, A. B., Ibrahim, R. H. (2018). Co-Production of AmpC and extended spectrum beta-lactamases in cephalosporin-resistant Acinetobacter baumannii in Egypt. World J. Microbiol. Biotechnol. 34 (12), 189. doi: 10.1007/s11274-018-2571-z

PubMed Abstract | CrossRef Full Text | Google Scholar

Schmieder, R., Edwards, R. (2011). Quality control and preprocessing of metagenomic datasets. Bioinformatics 27 (6), 863–864. doi: 10.1093/bioinformatics/btr026

PubMed Abstract | CrossRef Full Text | Google Scholar

Seemann, T. (2014). Prokka: rapid prokaryotic genome annotation. Bioinformatics 30 (14), 2068–2069. doi: 10.1093/bioinformatics/btu153

PubMed Abstract | CrossRef Full Text | Google Scholar

Vijayakumar, S., Jacob, J. J., Vasudevan, K., Mathur, P., Ray, P., Neeravi, A., et al. (2022). Genomic characterization of mobile genetic elements associated with carbapenem resistance of Acinetobacter baumannii from India. Front. Microbiol. 13. doi: 10.3389/fmicb.2022.869653

PubMed Abstract | CrossRef Full Text | Google Scholar

Wang, Y., Wu, C., Zhang, Q., Qi, J., Liu, H., Wang, Y., et al. (2012). Identification of new Delhi metallo-β-lactamase 1 in Acinetobacter lwoffii of food animal origin. PloS One 7 (5), e37152. doi: 10.1371/journal.pone.0037152

PubMed Abstract | CrossRef Full Text | Google Scholar

Wareth, G., Linde, J., Hammer, P., Splettstoesser, W. D., Pletz, M. W., Neubauer, H., et al. (2021). Molecular characterization of German Acinetobacter baumannii isolates and multilocus sequence typing (MLST) analysis based on WGS reveals novel STs. Pathog. (Basel Switzerland) 10 (6), 690. doi: 10.3390/pathogens10060690

CrossRef Full Text | Google Scholar

Wibberg, D., Salto, I. P., Eikmeyer, F. G., Maus, I., Winkler, A., Nordmann, P., et al. (2018). Complete genome sequencing of Acinetobacter baumannii strain K50 discloses the Large conjugative plasmid pK50a encoding carbapenemase OXA-23 and extended-spectrum β-lactamase GES-11. Antimicrob. Agents Chemother. 62 (5), e00212–e00218. doi: 10.1128/AAC.00212-18

PubMed Abstract | CrossRef Full Text | Google Scholar

Wood, D. E., Salzberg, S. L. (2014). Kraken: ultrafast metagenomic sequence classification using exact alignments. Genome Biol. 15 (3), R46. doi: 10.1186/gb-2014-15-3-r46

PubMed Abstract | CrossRef Full Text | Google Scholar

Woodford, N., Ellington, M. J., Coelho, J. M., Turton, J. F., Ward, M. E., Brown, S., et al. (2006). Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrobial Agents 27 (4), 351–353. doi: 10.1016/j.ijantimicag.2006.01.004

CrossRef Full Text | Google Scholar

Xanthopoulou, K., Urrutikoetxea-Gutiérrez, M., Vidal-Garcia, M., Diaz de Tuesta del Arco, J.-L., Sánchez-Urtaza, S., Wille, J., et al. (2020). First report of new Delhi metallo-β-Lactamase-6 (NDM-6) in a clinical Acinetobacter baumannii isolate from Northern Spain. Front. Microbiol. 11 (589253). doi: 10.3389/fmicb.2020.589253

CrossRef Full Text | Google Scholar

Zankari, E., Hasman, H., Cosentino, S., Vestergaard, M., Rasmussen, S., Lund, O., et al. (2012). Identification of acquired antimicrobial resistance genes. J. Antimicrobial Chemotherapy 67 (11), 2640–2644. doi: 10.1093/jac/dks261

CrossRef Full Text | Google Scholar